THE COMPARISON OF THE EFFICACY OF ONCE AND TWICE DAILY COLCHICINE DOSAGE IN PEDIATRIC PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER- A RANDOMIZED TRIAL

It was aimed to examine the efficacy and safety of once daily dosage schema of colchicine in pediatric patients with FMF compared to twice daily dosage schema.

In this 24-week, multicentric, randomized, controlled trial, pediatric patients newly diagnosed with FMF, carrying homozygote or compound heterozygote mutation and did not receive any treatment, were included. Patients were randomly assigned using block randomization method to receive treatment with once or twice daily doses. Clinical and laboratory characteristics and medication side effects were recorded and compared between groups. The study complied with Good Clinical Practice and the Consolidated Standards for Reporting of Trials (CONSORT) statement.

Project Admins:

• Erkan Demirkaya

Project start - end date: 01/04/2012 - 12/12/2012